联化科技(002250) - 2015年7月8日投资者关系活动记录表

Group 1: Project Developments - The first phase of the Texas Lianhua project has been completed on 260 acres, with the second phase currently in planning [1] - The design capacity of the phosgene facility in Texas Lianhua is set at a scale of 10,000 tons per year, with products including AKD, isocyanates, and acyl chlorides [1] - The Yancheng Lianhua pesticide project, ANBE, is currently in normal production and sales, generating expected benefits [1] Group 2: Business Improvements - The company is actively improving processes for AKD and other products, effectively reducing raw material costs and enhancing product quality [1] - The pharmaceutical intermediates business has faced slow development due to capacity, resource allocation, and market cycles, but new developments are anticipated with the completion of the Taizhou Lianhua plant and the establishment of a professional team [2] Group 3: Market Response - In response to recent significant fluctuations in the securities market, the company is formulating a plan to increase shareholding, demonstrating confidence in the capital market and the company's future [2]